Drug Trial Radar · NCT05742607
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Last checked: Nov 19, 2026Latest source record: Jun 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
70
Planned (sponsor's estimate)
Start
Jun 23, 2023
Primary completion
Jun 2027
Study completion Jun 2027
Sponsor
- Lead sponsor
- Innate PharmaIndustry
- Sponsor type
- Industry
- First posted
- Feb 24, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In Cohort 1, the study was intended to assess safety and efficacy of neoadjuvant combination of IPH5201 and durvalumab in addition to standard chemotherapy and adjuvant combination of IPH5201 and durvalumab, in untreated patients with resectable, early-stage (stage II to IIIA) non-small cell lung cancer (NSCLC). Study Design was updated following the results of interim analysis # 2 (protocol amendment, adding cohort 2). Cohort 2 includes patients with resectable Stage II to IIIB NSCLC expressing PD-L1 ≥1%, receiving (only) neoadjuvant IPH5201+ durvalumab + chemotherapy
Conditions
- Non Small Cell Lung Cancer
Interventions
IPH5201 + durvalumab + standard chemotherapyDrug
Patients will receive Neoadjuvant therapy with IPH5201 and durvalumab in addition to standard chemotherapy. In Cohort 1 only, Following surgery, patients will receive adjuvant treatment with IPH5201 and durvalumab.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pathological Complete Response (pCR)Time frame: 16 weeks after the first dose of study intervention.
- Adverse events (AEs) and serious adverse events (SAEs)Time frame: Until Day 90 after the last dose of study interventions.
Locations
30 sites in 5 countries. Site status is shown where the registry gives one.
St. Anthony's Hospital - BayCare Health System
St. Petersburg, Florida · Terminated
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida · Terminated
University of Chicago Medical Center
Chicago, Illinois · Withdrawn
Northwell Health Cancer Institute / Center for Novel Cancer Therapeutics
Lake Success, New York · Withdrawn
Millennium Research & Clinical Development
Houston, Texas · Terminated
UW Carbone Cancer Center - Cancer Connect
Madison, Wisconsin · Terminated
Angers University Hospital Center
Angers, France · Terminated
University Hospital Center Caen
Caen, France · Terminated
Hospital Calmette
Lille, France · Not yet recruiting
CHU de Limoges
Limoges, France · Recruiting
Leon Berard Center
Lyon, France · Recruiting
Marseille University Hospital Center - North Hospital
Marseille, France · Recruiting
Rennes University Hospital Center - Hospital Pontchaillou
Rennes, France · Recruiting
Charles Nicolle Hospital
Rouen, France · Terminated
Gustave Roussy
Villejuif, France · Recruiting
Henry Dunant Hospital Center
Athens, Greece · Withdrawn
University General Hospital "Attikon"
Athens, Greece · Recruiting
University General Hospital of Ioannina
Ioannina, Greece · Terminated
University General Hospital of Patras
Pátrai, Greece · Terminated
Koranyi National Institute of Pulmonology, 14th Department of Pulmonology
Budapest, Hungary · Recruiting
Veszprem County Pulmonology Institute
Farkasgyepű, Hungary · Terminated
Petz Aladar University Teaching Hospital, Department of Pulmonology
Győr, Hungary · Terminated
Jasz-Nagykun-Szolnok County Hetenyi Geza Hospital-Clinic, Department of Oncology
Szolnok, Hungary · Recruiting
Pulmonology Institute Torokbalint
Törökbálint, Hungary · Not yet recruiting
University Teaching Hospital in Bialystok, 2nd Department of Lung Diseases and Tuberculosis
Bialystok, Poland · Recruiting
John Paul II Specialist Hospital in Krakow
Krąków, Poland · Terminated
Mandziuk Slawomir - Specialist Medical Practice
Lublin, Poland · Terminated
Eugenia and Janusz Zeyland Wielkopolskie Centre of Pulmonology and Thoracic Surgery
Poznan, Poland · Terminated
Specialist Hospital in Prabuty Sp. z o.o. (LLC)
Prabuty, Poland · Recruiting
Military Institute of Medicine - National Research Institute
Warsaw, Poland · Terminated
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.